Malawi vs Senegal: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Malawi
91.0%
in 2025
Senegal
91.0%
in 2025
Malawi rank
61st
Senegal rank
61st
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Malawi
- Senegal
How they compare
Malawi currently reports 91.0% against 91.0% in Senegal, a difference of 0.0%.
The two have swapped places 6 times across 18 shared years of data; in 2008 it was Senegal ahead.
Malawi ranks 61st and Senegal ranks 61st of 194 countries.
Malawi has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malawi | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 72.1% | 53.8% | 18.3% | Malawi |
| 2020s | 91.2% | 88.5% | 2.7% | Malawi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Malawi or Senegal?
- Malawi, at 91.0% against 91.0% in Senegal as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Malawi and Senegal?
- 0.0%, with Malawi ahead.
- How many years of comparable data are there for Malawi and Senegal?
- 18 years are reported by both, from 2008 to 2025.
- How do Malawi and Senegal rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Malawi ranks 61st and Senegal ranks 61st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.